Guy T. Carter
23Patents
5h-index
19Co-inventors
66Inventor score
Filing activity: Jan 24, 1983 → Dec 13, 2006
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5106994A | Agents and method of production thereof | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5169956A | Macrolide antibiotic compounds | Emerging Cross-Sectional Technologies | 11 | Expired |
| US4705688A | Antibiotic LL-E19020 .alpha. and .beta. | Chemistry; Metallurgy | 8 | Expired |
| US4762949A | Acyl and carbamimidoyl alkanediamines | Chemistry; Metallurgy | 7 | Expired |
| US6713448B2 | Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5 | Human Necessities | 6 | Expired |
| US4968493A | Method for controlling chronic respiratory disease, fowl cholera and necrotic enteritis in avian species | Chemistry; Metallurgy | 5 | Expired |
| US4578468A | Antibiotic LL-D42067.beta. | Chemistry; Metallurgy | 5 | Expired |
| US5418168A | Biologically pure culture of the microorganism, streptomyces cyaneogriseus subspecies noncyanogenus, or a mutant thereof | Emerging Cross-Sectional Technologies | 3 | Expired |
| US4859598A | Antibiotic LL-D42067.beta. | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5096907A | Antibiotic LL-E19085 | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5432193A | Antibiotic LL-D37187.alpha. | Chemistry; Metallurgy | 2 | Expired |
| US5077277A | Chemical derivatives of antibiotics LL-E19020 alpha and beta | Chemistry; Metallurgy | 2 | Expired |
| US7183253B2 | Substantially pure glycopeptide antibiotics AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5 | Human Necessities | 1 | Expired |
| US5188945A | Recovery process for antibiotics LL-E19020 alpha and beta | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5510251A | Agents and method of production thereof | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5223430A | Subspecies of Micromonospora citrea which produces antibiotic LL-E19085 alpha | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7018996B2 | Antibiotics AW998A, AW998B, AW998C and AW998D | Human Necessities | 1 | Expired |
| US5814615A | Antibiotic LL-E19020 Alpha.sub.1 | Chemistry; Metallurgy | 0 | Expired |
| US6689763B2 | Antibiotics AA-896 | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5286745A | Antibiotics LL-E19020 Epsilon and LL-E19020 Epsilon.sub.1 | Chemistry; Metallurgy | 0 | Expired |
| US7078195B2 | Antibiotics AA-896 | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7696164B2 | Substantially pure glycopeptide antibiotics AC-98-1 ; AC-98-2; AC-98-3; AC-98-4 and AC-98-5 | Human Necessities | 0 | Active |
| US5814613A | Antibiotic LL-E19020 gamma | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.